[Sirolimus-eluting vs paclitaxel-eluting stents -- the trials confirm differences in clinical outcome].
Gil
Robert J
RJ
Klinika Kardiologii Inwazyjnej CSKMSWiA, Warszawa. robert.gil@cskmswia.pl
D015906:Angioplasty, Balloon, Coronary; D018849:Controlled Clinical Trials as Topic; D023903:Coronary Restenosis / Q000473:pathology / Q000517:prevention & control; D023921:Coronary Stenosis / Q000188:drug therapy*; D004343:Drug Implants; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D009204:Myocardial Revascularization / Q000295:instrumentation*; D017239:Paclitaxel / Q000008:administration & dosage*; D020123:Sirolimus / Q000008:administration & dosage*; D015607:Stents
D004343:Drug Implants; D007166:Immunosuppressive Agents; D017239:Paclitaxel; D020123:Sirolimus